180 Life Sciences Stock Buy Hold or Sell Recommendation
| ATNF Stock | USD 2.22 0.03 1.33% |
Given the investment horizon of 90 days and your highly speculative risk level, our recommendation regarding 180 Life Sciences is 'Strong Sell'. Macroaxis provides 180 Life buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding 180 Life positions.
Check out 180 Life Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as 180 and provide practical buy, sell, or hold advice based on investors' constraints. 180 Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
180 |
Execute 180 Life Buy or Sell Advice
The 180 recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on 180 Life Sciences. Macroaxis does not own or have any residual interests in 180 Life Sciences or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute 180 Life's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Modest | Details | |
Volatility | Very risky | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
180 Life Trading Alerts and Improvement Suggestions
| 180 Life Sciences is way too risky over 90 days horizon | |
| 180 Life Sciences appears to be risky and price may revert if volatility continues | |
| 180 Life Sciences has a very high chance of going through financial distress in the upcoming years | |
| 180 Life Sciences currently holds 1.05 M in liabilities with Debt to Equity (D/E) ratio of 0.02, which may suggest the company is not taking enough advantage from borrowing. 180 Life Sciences has a current ratio of 0.66, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about 180 Life's use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (19.94 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| 180 Life Sciences currently holds about 1.63 M in cash with (10.92 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.04. | |
| 180 Life Sciences has a poor financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: ARMISTICE CAPITAL, LLC Acquires New Stake in 180 Life Sciences C - GuruFocus.com |
180 Life Returns Distribution Density
The distribution of 180 Life's historical returns is an attempt to chart the uncertainty of 180 Life's future price movements. The chart of the probability distribution of 180 Life daily returns describes the distribution of returns around its average expected value. We use 180 Life Sciences price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of 180 Life returns is essential to provide solid investment advice for 180 Life.
| Mean Return | 3.32 | Value At Risk | -11.29 | Potential Upside | 16.10 | Standard Deviation | 41.39 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of 180 Life historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
180 Stock Institutional Investors
| Shares | Tower Research Capital Llc | 2024-06-30 | 6.3 K | Blackrock Inc | 2024-06-30 | 772 | Bank Of America Corp | 2024-06-30 | 12.0 | Royal Bank Of Canada | 2024-06-30 | 11.0 | Qube Research & Technologies | 2024-06-30 | 2.0 | Semmax Financial Advisors Inc. | 2024-06-30 | 1.0 | Jpmorgan Chase & Co | 2024-06-30 | 1.0 | Wells Fargo & Co | 2024-06-30 | 0.0 | Ifp Advisors, Llc | 2024-06-30 | 0.0 | Charles Schwab Investment Management Inc | 2024-06-30 | 0.0 | Citadel Advisors Llc | 2024-06-30 | 0.0 |
180 Life Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | (483.8K) | (8.7M) | 2.0M | (1.3M) | (5.0M) | (4.7M) | |
| Net Income | (14.5K) | (25.4M) | (10.9M) | (38.7M) | (19.9M) | (20.9M) | |
| End Period Cash Flow | 270.9K | 83.4K | 2.1M | 7.0M | 2.0M | 1.9M | |
| Free Cash Flow | (3.9K) | (3.5M) | (3.9M) | (12.1M) | (10.9M) | (10.4M) | |
| Other Non Cash Items | 5.7M | 717.7K | 3.5M | 22.1M | 9.0M | 6.3M |
180 Life Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to 180 Life or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that 180 Life's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a 180 stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 2.58 | |
β | Beta against Dow Jones | 6.17 | |
σ | Overall volatility | 42.03 | |
Ir | Information ratio | 0.08 |
180 Life Volatility Alert
180 Life Sciences is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure 180 Life's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact 180 Life's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.180 Life Fundamentals Vs Peers
Comparing 180 Life's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze 180 Life's direct or indirect competition across all of the common fundamentals between 180 Life and the related equities. This way, we can detect undervalued stocks with similar characteristics as 180 Life or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of 180 Life's fundamental indicators could also be used in its relative valuation, which is a method of valuing 180 Life by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare 180 Life to competition |
| Fundamentals | 180 Life | Peer Average |
| Return On Equity | -3.99 | -0.31 |
| Return On Asset | -0.63 | -0.14 |
| Current Valuation | 7.45 M | 16.62 B |
| Shares Outstanding | 1.98 M | 571.82 M |
| Shares Owned By Insiders | 4.34 % | 10.09 % |
| Shares Owned By Institutions | 3.45 % | 39.21 % |
| Number Of Shares Shorted | 139.43 K | 4.71 M |
| Price To Earning | 0.63 X | 28.72 X |
| Price To Book | 1.18 X | 9.51 X |
| EBITDA | (22.13 M) | 3.9 B |
| Net Income | (19.94 M) | 570.98 M |
| Cash And Equivalents | 1.63 M | 2.7 B |
| Cash Per Share | 0.04 X | 5.01 X |
| Total Debt | 1.05 M | 5.32 B |
| Debt To Equity | 0.02 % | 48.70 % |
| Current Ratio | 0.67 X | 2.16 X |
| Book Value Per Share | (0.24) X | 1.93 K |
| Cash Flow From Operations | (10.92 M) | 971.22 M |
| Short Ratio | 0.03 X | 4.00 X |
| Earnings Per Share | 7.98 X | 3.12 X |
| Target Price | 80.0 | |
| Number Of Employees | 4 | 18.84 K |
| Beta | 0.25 | -0.15 |
| Market Capitalization | 4.39 M | 19.03 B |
| Total Asset | 5.26 M | 29.47 B |
| Retained Earnings | (127.34 M) | 9.33 B |
| Working Capital | (1.42 M) | 1.48 B |
| Net Asset | 5.26 M |
Note: Insider Trading [view details]
180 Life Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as 180 . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About 180 Life Buy or Sell Advice
When is the right time to buy or sell 180 Life Sciences? Buying financial instruments such as 180 Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having 180 Life in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Target Outcome ETFs Thematic Idea Now
Target Outcome ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Target Outcome ETFs theme has 93 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Target Outcome ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out 180 Life Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of 180 Life. If investors know 180 will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about 180 Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 7.98 | Return On Assets (0.64) | Return On Equity (3.99) |
The market value of 180 Life Sciences is measured differently than its book value, which is the value of 180 that is recorded on the company's balance sheet. Investors also form their own opinion of 180 Life's value that differs from its market value or its book value, called intrinsic value, which is 180 Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because 180 Life's market value can be influenced by many factors that don't directly affect 180 Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between 180 Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if 180 Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, 180 Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.